Cognizant has secured a contract from Clario, a healthcare research technology company specializing in delivering endpoint solutions for clinical trials.
The technology deal with Cognizant is set to propel Clario’s mission of revolutionizing clinical research through the generation of high-quality evidence for informed decision-making, by enhancing its employee and customer offerings. Cognizant did not reveal the size of the technology deal.
Jay Ferro, EVP, Chief Information, Technology & Product Officer at Clario, expressed confidence in the partnership, stating, “Cognizant’s innovative technology and industry expertise made them the natural choice to partner on the next phase of our digital transformation journey.”
Clario specializes in developing digital solutions that redefine possibilities in clinical trials, focusing on enhancing accuracy, reliability, speed, and efficiency in data gathering and analysis processes. Over the course of the five-year collaboration, Clario intends to leverage Cognizant’s experience in automation and digital technologies to modernize processes and experiences.
“Clinical trials require reliable technology to manage patient data, monitor results, ensure regulations are met, and more. Clario is doing groundbreaking work in providing this technology to run clinical trials, and Cognizant is excited to work alongside them to modernize their offerings,” Mohammad Haque, SVP, Global Large Deals Lead and BU Head, Life Sciences at Cognizant, said.
